Literature DB >> 33278652

Deep intronic TIMMDC1 variant delays diagnosis of rapidly progressive complex I deficiency.

Myrthe Naber1, Debby Hellebrekers2, Rutger A J Nievelstein3, Peter M van Hasselt4, Richard H van Jaarsveld1, Inge Cuppen5, Renske Oegema6.   

Abstract

Complex I deficiency is the most common pediatric mitochondrial disease. It can cause a wide range of clinical disorders, including Leigh syndrome. TIMMDC1 encodes an assembly protein of complex I and has been recently associated with early onset mitochondrial disease in three unrelated families. In all three families the same homozygous deep intronic variant was identified leading to inclusion of a new exon resulting in a frameshift and premature stop codon (c.596 + 2146A > G, p.Gly199_Thr200ins5*). Herein, we describe two brothers of Dutch descent, presenting in infancy with hypotonia and respiratory insufficiency and a rapidly progressive and fatal disease course. Laboratory findings and metabolic investigations revealed no specific abnormalities, notably no raised plasma lactate. MRI showed transient lesions in the basal ganglia of brother 1. A muscle biopsy demonstrated complex I deficiency in brother 2. Exome sequencing yielded a novel heterozygous TIMMDC1 variant: c.385C > T, p.(Arg129*). Targeted sequencing revealed the previously published deep intronic variant c.596 + 2146A > G, p.(Gly199_Thr200ins5*) on the second allele which is not detected by exome sequencing. In summary, we present the fourth family with TIMMDC1-related disease, with a novel nonsense variant. This report illustrates the importance of considering mitochondrial disease even when laboratory findings are normal, and the added value of targeted sequencing of introns.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Complex 1 deficiency; Genetics; Intronic variant; Mitchondrial disease; TIMMDC1

Mesh:

Substances:

Year:  2020        PMID: 33278652     DOI: 10.1016/j.ejmg.2020.104120

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  1 in total

1.  Oligonucleotide correction of an intronic TIMMDC1 variant in cells of patients with severe neurodegenerative disorder.

Authors:  Raman Kumar; Mark A Corbett; Nicholas J C Smith; Daniella H Hock; Zoya Kikhtyak; Liana N Semcesen; Atsushi Morimoto; Sangmoon Lee; David A Stroud; Joseph G Gleeson; Eric A Haan; Jozef Gecz
Journal:  NPJ Genom Med       Date:  2022-01-28       Impact factor: 6.083

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.